Squamous Cell Carcinoma of the Larynx

Explore clinical trials studying Squamous Cell Carcinoma of the Larynx. Study availability and eligibility vary by location and protocol.

7 public trials 4 recruiting studies

Refine in advanced search Browse all conditions

Squamous Cell Carcinoma of the Larynx trial results

Recruiting

Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer

NCT03114462

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +7 more
Locations: MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

De-Intensification of Postoperative Radiotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck

NCT06030440

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +9 more
Locations: Universitätsklinikum Erlangen, Strahlenklinik Erlangen, Bavaria, Germany

View Trial Details

Recruiting

Head and Neck Carcinoma Clinical Research Platform for Molecular and Blood-based Biomarkers, Treatment and Outcome

NCT06380686

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +9 more
Locations: Universitätsklinikum Essen Essen, Germany

Onkologie/Studienzentrum am Raschplatz GbR Hanover, Germany

View Trial Details

Recruiting

European Larynx Organ Preservation Study (ELOS) [MK-3475-C44]

NCT06137378

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +21 more
Locations: Universitätsklinikum Mannheim, Klinik für Hals-Nasen-Ohrenheilkunde Theodor-Kutzer-Ufer 1-3 Mannheim, Baden-Würtemberg, Germany

Universitätsklinikum Ulm / Ulm University Medical Center, Klinik für Hals- Nasen-Ohrenheilkunde und Kopf-Halschirurgie, Frauensteige 12 Ulm, Baden-Würtemberg, Germany

Klinikum rechts der Isar der TU München, Klinik und Poliklinik für Hals-, Nasen- und Ohrenheilkunde, Ismaninger Straße 22 München, Bavaria, Germany

Universität Regensburg, Klinik und Poliklinik für Strahlentherapie Franz-Josef-Strauss-Allee 11 Regensburg, Bavaria, Germany

View Trial Details

Not Yet Recruiting

Fluorescence-guided Surgery in Laryngeal- and Hypopharyngeal Cancer: a Feasibility Trial

NCT05752149

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +7 more
Locations: Erasmus Medical Center Rotterdam, South Holland, Netherlands

View Trial Details

Completed

Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma

NCT03370276

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Carcinoma, +14 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

Emory University School of Medicine Atlanta, Georgia, United States

The Ohio State University Columbus, Ohio, United States

View Trial Details

Active, Not Recruiting

Testing the Safety of Giving a Standard Dose of Radiation Over a Shorter Period of Time for Patients Who Had Surgery for Intermediate-Risk Head and Neck Cancer

NCT05540899

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +10 more
Locations: Milton S. Hershey Medical Center Hershey, Pennsylvania, United States

View Trial Details

Squamous Cell Carcinoma of the Larynx

Squamous Cell Carcinoma of the Larynx trial results

Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer

De-Intensification of Postoperative Radiotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck

Head and Neck Carcinoma Clinical Research Platform for Molecular and Blood-based Biomarkers, Treatment and Outcome

European Larynx Organ Preservation Study (ELOS) [MK-3475-C44]

Fluorescence-guided Surgery in Laryngeal- and Hypopharyngeal Cancer: a Feasibility Trial

Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma

Testing the Safety of Giving a Standard Dose of Radiation Over a Shorter Period of Time for Patients Who Had Surgery for Intermediate-Risk Head and Neck Cancer

Related conditions